JPMORGAN CHASE & CO - CARDIOME PHARMA CORP ownership

CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 26 filers reported holding CARDIOME PHARMA CORP in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CARDIOME PHARMA CORP
ValueSharesWeighting
Q1 2018$395,000
+58.0%
170,093
+5.4%
0.00%
Q4 2017$250,000
-24.0%
161,450
+1.7%
0.00%
Q3 2017$329,000
-53.1%
158,697
+2.3%
0.00%
Q2 2017$701,000
+106.8%
155,095
+37.6%
0.00%
Q1 2017$339,000
+124.5%
112,679
+105.3%
0.00%
Q4 2016$151,000
+843.8%
54,897
+954.5%
0.00%
Q3 2016$16,0005,206
+260200.0%
0.00%
Q2 2016$0
-100.0%
2
-99.7%
0.00%
Q1 2016$2,000602
+30000.0%
0.00%
Q4 2015$020.00%
Other shareholders
CARDIOME PHARMA CORP shareholders Q4 2017
NameSharesValueWeighting ↓
Alistair Capital Management, L.L.C. 917,400$5,715,0002.56%
Fortress Investment Group LLC 2,481,596$15,460,0000.24%
PERKINS CAPITAL MANAGEMENT INC 14,000$87,0000.06%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,332,260$8,386,0000.02%
TFS CAPITAL LLC 26,116$163,0000.01%
GROUP ONE TRADING, L.P. 54,815$342,0000.01%
Renaissance Technologies 218,913$1,364,0000.00%
Alberta Investment Management Corp 19,140$128,0000.00%
OAK RIDGE INVESTMENTS LLC 11,055$69,0000.00%
CLEAR STREET MARKETS LLC 600$4,0000.00%
View complete list of CARDIOME PHARMA CORP shareholders